Executives and directors at Pfizer, Moderna and other companies developing Covid-19 vaccines sold approximately $496 million of stock last year, reaping the rewards of positive vaccine developments on.wsj.com
@qz.com4 years ago
What’s going to happen to all those other Covid-19 vaccine candidates?
@WSJ3 years ago
Vaccine makers Pfizer and Moderna have both named company outsiders as chief financial officers as the companies look to deploy some of the cash they generated during the Covid-19 pandemic on.wsj.com
@WSJ4 years ago
Executives and directors at Pfizer, Moderna and other companies developing Covid-19 vaccines sold approximately $496 million of stock last year, reaping the rewards of positive vaccine developments on.wsj.com
@forbes.com4 years ago
Moderna, Novavax, Pfizer: How Are Coronavirus Vaccine Stocks Faring?
@truthout.org4 years ago
Pfizer and Moderna Hike EU Vaccine Prices as Rich Countries Oppose Patent Waiver
@forbes.com4 years ago
Superyacht Service Expands Down Under
@forbes.com4 years ago
Vaccine Watch: Investors Await Pfizer, Moderna Results, Monitor Gilead Treatment
@forbes.com4 years ago
How The Covid-19 Vaccine Injected Billions Into Big Pharma—And Made Its Executives Very Rich
@cbsnews.com4 years ago
White House hosts summit on COVID vaccines without companies that produced shots